1. ImmunoPrecise Antibodies will hold an earnings call on July 29, 2025. 2. The call will cover quarterly results and recent business highlights. 3. Shareholders can attend via phone or webcast. 4. Company utilizes Bio-Native AI for drug discovery and diagnostics. 5. Financial results will precede the conference call.
Upcoming earnings report with potential positive results could attract investor interest, similar to previous trends in biotech stocks after quarterly earnings. Companies in the bio-tech sector that successfully innovate often see a boost in their stock price following positive quarterly earnings.
Earnings announcements are critical for stock evaluation, especially in biotechnology, where innovation can lead to significant valuation changes.
The earnings call will provide immediate insights into the company’s financial health, impacting investor sentiment shortly after the announcement.
AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for fourth quarter and full fiscal year end 2025, on Tuesday, July 29, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. ImmunoPrecise management will host the conference call followed by a question-and-answer period.
Conference Call and Webcast Details
The Company will host a live conference call and webcast to discuss these results and provide a corporate update on Tuesday, July 29th, 2025, at 10:30AM ET.
The conference call will be webcast live and available for replay via a link provided in the Events section of the Company’s IR pages at https://ir.ipatherapeutics.com/events-and-presentations/default.aspx.
***Participant Dial-In Details***
Joining by Phone
USA / International Toll +1 (646) 307-1963
USA - Toll-Free (800) 715-9871
Participants call one of the allocated dial-in numbers and advise the Operator of either the Conference ID 3224490 or Conference Name.
Webcast Attendee URL
https://events.q4inc.com/attendee/710965397
Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization.
Anyone listening to the call is encouraged to read the company's periodic reports available on the company’s profile at www.sedarplus.com and www.sec.gov, including the discussion of risk factors and historical results of operations and financial condition in those reports.
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is advancing Bio-Native™ AI at the intersection of biology and computation. The Company’s LENSai™ and HYFT® platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering next-generation workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology.